Advertisement
Corrigendum Free access | 10.1172/JCI65883
Find articles by Sachs, N. in: JCI | PubMed | Google Scholar
Find articles by Claessen, N. in: JCI | PubMed | Google Scholar
Find articles by Aten, J. in: JCI | PubMed | Google Scholar
Find articles by Kreft, M. in: JCI | PubMed | Google Scholar
Find articles by Teske, G. in: JCI | PubMed | Google Scholar
Find articles by Koeman, A. in: JCI | PubMed | Google Scholar
Find articles by Zuurbier, C. in: JCI | PubMed | Google Scholar
Find articles by Janssen, H. in: JCI | PubMed | Google Scholar
Find articles by Sonnenberg, A. in: JCI | PubMed | Google Scholar
Published September 4, 2012 - More info
Podocytes of the kidney adhere tightly to the underlying glomerular basement membrane (GBM) in order to maintain a functional filtration barrier. The clinical importance of podocyte binding to the GBM via an integrin-laminin-actin axis has been illustrated in models with altered function of α3β1 integrin, integrin-linked kinase, laminin-521, and α-actinin 4. Here we expanded on the podocyte-GBM binding model by showing that the main podocyte adhesion receptor, integrin α3β1, interacts with the tetraspanin CD151 in situ in humans. Deletion of Cd151 in mouse glomerular epithelial cells led to reduced adhesive strength to laminin by redistributing α3β1 at the cell-matrix interface. Moreover, in vivo podocyte-specific deletion of Cd151 led to glomerular nephropathy. Although global Cd151-null B6 mice were not susceptible to renal disease, as has been shown previously, increasing blood and transcapillary filtration pressure induced nephropathy in these mice. Importantly, blocking the angiotensin-converting enzyme in renal disease–susceptible global Cd151-null FVB mice prolonged their median life span. Together, these results establish CD151 as a crucial modifier of integrin-mediated adhesion of podocytes to the GBM and show that blood pressure is an important factor in the initiation and progression of Cd151 knockout–induced nephropathy.
Norman Sachs, Nike Claessen, Jan Aten, Maaike Kreft, Gwendoline J.D. Teske, Anneke Koeman, Coert J. Zuurbier, Hans Janssen, Arnoud Sonnenberg
Original citation: J. Clin. Invest. 2012;122(1):348–358. doi:10.1172/JCI58878.
Citation for this corrigendum: J. Clin. Invest. 2012;122(9):3368. doi:10.1172/JCI65883.
During the preparation of this manuscript, funding information was inadvertently omitted. The sentence below should be added to Acknowledgments.
The study was supported by the Dutch Kidney Foundation (grant C07.2232).
The authors regret the error.